Balinsua, April Rose Y.

HRN: 27-68-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2025
CEFTRIAXONE 1G (VIAL)
08/31/2025
09/07/2025
IV
2gms
OD X 7 Days
T/C Endometritis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines